Jun 30, 2023
1:20
For every 20 shares held, investors received 1. The price per share adjusted from $0.16 to $0.01.
The split itself did not change the total investment value.
Evelo Biosciences, Inc. (EVLO) trades on the Other OTC in the Biotechnology industry.
Evelo Biosciences, Inc. company overviewThe latest split shown was on June 30, 2023. It was a 1-for-20 reverse split, so shareholders received 1 share for every 20 they held.
This history records one reverse split, on June 30, 2023.